Our results, showing that IL-2 immune complex can promote the breakdown of peripheral tolerance by memory-like CD8+ T cells in the absence of CD4+ T cells help, have important implications for the development of therapies for autoimmune diseases as well as cancer immunotherapies. Here, CD8A is linked to cancer.